150 related articles for article (PubMed ID: 16699296)
1. Serum PSA levels are not affected by the menstrual cycle or the menopause, but are increased in subjects with polycystic ovary syndrome.
Burelli A; Cionini R; Rinaldi E; Benelli E; Fiore E; Canale D; Bencivelli W; Nencetti C; Pinchera A; Pucci E
J Endocrinol Invest; 2006 Apr; 29(4):308-12. PubMed ID: 16699296
[TBL] [Abstract][Full Text] [Related]
2. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
Vural B; Ozkan S; Bodur H
J Obstet Gynaecol Res; 2007 Apr; 33(2):166-73. PubMed ID: 17441890
[TBL] [Abstract][Full Text] [Related]
3. Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination.
Bahceci M; Bilge M; Tuzcu A; Tuzcu S; Bahceci S
J Endocrinol Invest; 2004 Apr; 27(4):353-6. PubMed ID: 15233555
[TBL] [Abstract][Full Text] [Related]
4. Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume.
Saxena R; Bjonnes AC; Georgopoulos NA; Koika V; Panidis D; Welt CK
Hum Reprod; 2015 Jul; 30(7):1697-703. PubMed ID: 25994816
[TBL] [Abstract][Full Text] [Related]
5. Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome - a new insight.
Rudnicka E; Radowicki S; Suchta K
Gynecol Endocrinol; 2016 Nov; 32(11):931-935. PubMed ID: 27426018
[TBL] [Abstract][Full Text] [Related]
6. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
Holte J; Bergh T; Gennarelli G; Wide L
Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
[TBL] [Abstract][Full Text] [Related]
7. Prostatic-specific antigen (PSA) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis.
Wu ZH; Tang Y; Niu X; Pu FF; Xiao XY; Kong W
J Ovarian Res; 2019 Oct; 12(1):94. PubMed ID: 31615559
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic daily oral administration of 17 beta-oestradiol and norethisterone on the isoforms of serum gonadotrophins in post-menopausal women.
Wide L; Naessén T; Phillips DJ
Clin Endocrinol (Oxf); 1995 Jan; 42(1):59-64. PubMed ID: 7889633
[TBL] [Abstract][Full Text] [Related]
9. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of inhibins are differentially altered in patients with polycystic ovary syndrome: effects of being overweight and relevance to hyperandrogenism.
Pigny P; Cortet-Rudelli C; Decanter C; Deroubaix D; Soudan B; Duhamel A; Dewailly D
Fertil Steril; 2000 May; 73(5):972-7. PubMed ID: 10785223
[TBL] [Abstract][Full Text] [Related]
11. Serum prostate-specific antigen concentration is increased in acromegalic women.
Manetti L; Lupi I; Genovesi M; Morselli L; Grasso L; Nencetti C; Gasperi M; Bogazzi F; Bartalena L; Martino E
J Endocrinol Invest; 2004; 27(7):643-7. PubMed ID: 15505987
[TBL] [Abstract][Full Text] [Related]
12. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of prostate-specific antigen (PSA) and free prostate specific antigen (fPSA) in women with ovulatory and anovulatory polycystic ovary syndrome.
UKINC K; Ersoz HO; Erem C; Hacihasanoglu AB
Endocrine; 2009 Feb; 35(1):123-9. PubMed ID: 19009369
[TBL] [Abstract][Full Text] [Related]
14. Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome.
Puurunen J; Piltonen T; Jaakkola P; Ruokonen A; Morin-Papunen L; Tapanainen JS
J Clin Endocrinol Metab; 2009 Jun; 94(6):1973-8. PubMed ID: 19318449
[TBL] [Abstract][Full Text] [Related]
15. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
Adams JM; Taylor AE; Crowley WF; Hall JE
J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
18. The Value of Prostate-Specific Antigen in Diagnosis of Polycystic Ovarian Syndrome in Adolescent Girls.
Tokmak A; Bodur S; Erkilinc S; Ozel S; Engin-Ustun Y
J Pediatr Adolesc Gynecol; 2018 Jun; 31(3):263-269. PubMed ID: 29162532
[TBL] [Abstract][Full Text] [Related]
19. Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer.
Pujol P; Daurès JP; Brouillet JP; Maudelonde T; Rochefort H; Grenier J
Br J Cancer; 1999 Feb; 79(5-6):909-14. PubMed ID: 10070889
[TBL] [Abstract][Full Text] [Related]
20. [Serum inhibin B in polycystic ovary syndrome as a potential marker of ovarian dysfunction].
Cetković A
Srp Arh Celok Lek; 2008; 136(7-8):379-83. PubMed ID: 18959173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
